helium has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feldman, LC; Kasaei, L; Kolloli, A; Kumar, R; Merolli, A; Ramasamy, S; Subbian, S | 1 |
Bykov, VI; Chuchalin, AG; Gavrilov, PV; Panin, AA; Petrikov, SS; Ryabokon, AM; Shogenova, LV; Tsybenova, SB; Utkina, II; Varfolomeev, SD; Zhuravel, SV | 1 |
1 trial(s) available for helium and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Thermovaccination - thermoheliox as a stimulator of the immune response. Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection.
Topics: Administration, Inhalation; Adult; Aged; Antibodies, Viral; C-Reactive Protein; COVID-19; Helium; Hot Temperature; Humans; Hyperthermia, Induced; Immunoglobulin G; Immunoglobulin M; Kinetics; Middle Aged; Models, Immunological; Oxygen; SARS-CoV-2; Vaccination | 2021 |
1 other study(ies) available for helium and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy.
Topics: Angiotensin-Converting Enzyme 2; Animals; Chlorocebus aethiops; COVID-19; Cytoplasm; Extracellular Vesicles; Giant Cells; Helium; Humans; Ions; Microscopy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Internalization | 2022 |